IVVD logo

IVVD
Invivyd Inc

5,911
Mkt Cap
$412.89M
Volume
1.41M
52W High
$3.07
52W Low
$0.483
PE Ratio
-4.07
IVVD Fundamentals
Price
$1.46
Prev Close
$1.51
Open
$1.51
50D MA
$1.59
Beta
1.35
Avg. Volume
2.81M
EPS (Annual)
-$0.3048
P/B
1.70
Rev/Employee
$437,918.03
$201.17
Loading...
Loading...
News
all
press releases
Invivyd, Inc. (NASDAQ:IVVD) Receives Consensus Rating of "Hold" from Analysts
Shares of Invivyd, Inc. (NASDAQ:IVVD - Get Free Report) have been given a consensus recommendation of "Hold" by the six research firms that are covering the company, MarketBeat reports. One equities...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
Invivyd Updates VYD2311 REVOLUTION Trials, Modestly Upsizes Study, Unveils Measles mAb VMS-063
Invivyd (NASDAQ:IVVD) provided updates on its REVOLUTION program for COVID-19 monoclonal antibody candidate VYD2311 and announced the discovery and early development work for a measles monoclonal antibody candidate, VMS-063, during a conference call led by board chairman Marc Elia alongside Chief Sc...
MarketBeat·17d ago
News Placeholder
Invivyd Stock Surges As FDA Alignment Boosts COVID-19 Program
Invivyd expands VYD2311 COVID study, delays timeline to Q3 2026, and advances measles antibody VMS063 toward clinical development.read more...
Benzinga·17d ago
News Placeholder
Invivyd, Inc. (NASDAQ:IVVD) Given Consensus Rating of "Hold" by Analysts
Invivyd, Inc. (NASDAQ:IVVD - Get Free Report) has received an average rating of "Hold" from the six ratings firms that are presently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and t...
MarketBeat·26d ago
News Placeholder
FY2027 Earnings Estimate for Invivyd Issued By HC Wainwright
Invivyd, Inc. (NASDAQ:IVVD - Free Report) - HC Wainwright reduced their FY2027 EPS estimates for shares of Invivyd in a research report issued to clients and investors on Tuesday, March 10th. HC...
MarketBeat·2mo ago
News Placeholder
Invivyd (NASDAQ:IVVD) Stock Price Up 6.3% - Still a Buy?
Invivyd (NASDAQ:IVVD) Trading 6.3% Higher - Still a Buy...
MarketBeat·2mo ago
News Placeholder
Invivyd, Inc. (NASDAQ:IVVD) Receives Average Rating of "Hold" from Analysts
Shares of Invivyd, Inc. (NASDAQ:IVVD - Get Free Report) have been given an average rating of "Hold" by the six ratings firms that are covering the firm, MarketBeat reports. One equities research...
MarketBeat·2mo ago
News Placeholder
Invivyd Q4 Earnings Call Highlights
Invivyd (NASDAQ:IVVD) executives used the company's fourth-quarter 2025 earnings call to outline progress in its COVID-19 monoclonal antibody pipeline, provide an update on commercialization of...
MarketBeat·2mo ago
News Placeholder
Invivyd Q4 Earnings Assessment
read more...
Benzinga·2mo ago
News Placeholder
An Overview of Invivyd's Earnings
read more...
Benzinga·2mo ago
<
1
2
...
>

Latest IVVD News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.